Advertisement

Maryland group attacks high cost of prescription drugs

By Associated Press  |  September 28, 2016

The Maryland Citizens' Health Initiative, a coalition of more than 1,200 religious, labor, business and policy groups seeking quality and affordable health care, wants the state Legislature to address high drug costs by overhauling some of the laws governing drug pricing.

Think tank proposes letting Medicare negotiate drug prices

By Shannon Muchmore  |  September 26, 2016

The Center for American Progress released a paper Monday outlining a method for pricing drugs based on their value through the use of comparative-effectiveness research and an arbitration process.

Pfizer chooses to not break up business

By Associated Press  |  September 26, 2016

The company said Monday it believes it is best positioned to maximize shareholder value in its current form, but it reserves the right to split in the future if the situation changes.

FDA approves lower-cost alternative to biotech drug Humira

By Associated Press  |  September 24, 2016

Federal regulators have approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.

Extending EpiPen shelf life could be a relief for patients, costly for Mylan

Extending EpiPen shelf life could be a relief for patients, costly for Mylan

By Adam Rubenfire  |  September 22, 2016

Mylan CEO Heather Bresch's recent announcement that Mylan is looking to extend the shelf life of the EpiPen could be a relief for patients, but a costly move for Mylan since it may take significant research and development to change epinephrine, the drug inside the EpiPen.

Mylan CEO defends EpiPen cost to angry lawmakers

Mylan CEO defends EpiPen cost to angry lawmakers

By Associated Press  |  September 21, 2016

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company with sales in excess of $11 billion.

LabCorp announces new Covance CEO

LabCorp announces new Covance CEO

By Adam Rubenfire  |  September 20, 2016

Laboratory Corporation of America has announced the next CEO of its Covance drug development division, just two weeks after Deborah Keller announced she would resign.

HHS makes it harder for clinical researchers to avoid sharing trial data

HHS makes it harder for clinical researchers to avoid sharing trial data

By Adam Rubenfire  |  September 16, 2016

HHS on Friday finalized a rule that expands and clarifies what clinical-trial data legally needs to be made public. The goal is to help scientists, doctors and patients learn more about ongoing research and potentially ease access to experimental treatments.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.